SRIAM LABS PRIVATE LIMITED

N/A | U24239AP2002PTC121365

Company Overview

Sriam Labs Private Limited is registered under CIN U24239AP2002PTC121365. It was incorporated on 12 Feb 2002 and is recorded as a Private entity in the Company limited by shares category. Its current registry status is Active, its origin is listed as Indian, and its listing status is Unlisted. The registered office is recorded at 03rd Floor, Laurus Enclave, Plot Office 01Edulapaka Bonangi Village, Parawada Mandal, Anakapalli District, Anakapalle, Andhra Pradesh, 531021. A separate business address is recorded at -, -, -, -. The registered activity classification includes Manufacture of other pharmaceutical and botanical products n.e.c.. The profile also organizes available capital, directors, charges, registration identifiers and compliance information for due-diligence reference. Values reflect the latest public records received by the platform and may change when statutory filings or registry corrections are processed. Users should verify material decisions against the relevant official filing or authority record.

Total charges

12

Open charges

0

Closed charges

12

Requiring review

0

Open registered amount (Crore)

₹ 0.00

Amount data

Complete

0 excluded from amount

Source: Company charge register · Registered charge amount; not an outstanding loan balance

Charge IDBank NameAmount (Crore)StatusCreation DateModification DateSatisfaction Date
10402446-₹5.6Closed28 Jan 2013-06 Feb 2018
10510075-₹6Closed18 Jun 2014-06 Feb 2018
90339236-₹0.47Closed19 Sept 2002-11 Jan 2005
10548656-₹0.07Closed21 Jan 2015-06 Feb 2018
10570646-₹6Closed30 Apr 2015-06 Feb 2018
10357513-₹2Closed10 May 2012-01 Mar 2013
10073290-₹9.65Closed28 Sept 200724 Jun 200921 Oct 2011
10329341-₹1.82Closed23 Nov 2011-24 Aug 2012
90339319-₹7.65Closed19 May 200518 Jul 200528 Sept 2007
10338554-₹5.88Closed14 Feb 2012-08 Nov 2017
10308211ANDHRA BANK₹29.6Closed05 Sept 201106 Feb 201818 Mar 2020
100406914Axis bank Limited₹10Closed29 Dec 202009 Mar 202102 Jul 2022
Loading secure access…